3,117
Views
40
CrossRef citations to date
0
Altmetric
Review

STAT3 and the Hyper-IgE syndrome

Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties

Article: e23435 | Received 02 Dec 2012, Accepted 28 Dec 2012, Published online: 01 Apr 2013

References

  • Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity 2012; 36:515 - 28; http://dx.doi.org/10.1016/j.immuni.2012.03.016; PMID: 22520845
  • O’Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012; 36:542 - 50; http://dx.doi.org/10.1016/j.immuni.2012.03.014; PMID: 22520847
  • Harrison DA. The Jak/STAT pathway. Cold Spring Harb Perspect Biol 2012; 4:a011205; http://dx.doi.org/10.1101/cshperspect.a011205; PMID: 22383755
  • Ghoreschi K, Laurence A, O’Shea JJ. Janus kinases in immune cell signaling. Immunol Rev 2009; 228:273 - 87; http://dx.doi.org/10.1111/j.1600-065X.2008.00754.x; PMID: 19290934
  • Darnell JE Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415 - 21; http://dx.doi.org/10.1126/science.8197455; PMID: 8197455
  • Stark GR, Darnell JE Jr.. The JAK-STAT pathway at twenty. Immunity 2012; 36:503 - 14; http://dx.doi.org/10.1016/j.immuni.2012.03.013; PMID: 22520844
  • Debnath B, Xu S, Neamati N. Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein. J Med Chem 2012; 55:6645 - 68; http://dx.doi.org/10.1021/jm300207s; PMID: 22650325
  • Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994; 77:63 - 71; http://dx.doi.org/10.1016/0092-8674(94)90235-6; PMID: 7512451
  • Zhong Z, Wen Z, Darnell JE Jr.. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264:95 - 8; http://dx.doi.org/10.1126/science.8140422; PMID: 8140422
  • Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, et al. Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A 2010; 107:21499 - 504; http://dx.doi.org/10.1073/pnas.1016147107; PMID: 21098664
  • Yuan ZL, Guan YJ, Chatterjee D, Chin YE. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005; 307:269 - 73; http://dx.doi.org/10.1126/science.1105166; PMID: 15653507
  • Davis SD, Schaller J, Wedgwood RJ. Job’s Syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet 1966; 1:1013 - 5; http://dx.doi.org/10.1016/S0140-6736(66)90119-X; PMID: 4161105
  • Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci 2012; 1250:25 - 32; http://dx.doi.org/10.1111/j.1749-6632.2011.06387.x; PMID: 22268731
  • Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972; 49:59 - 70; PMID: 5059313
  • Smithwick EM, Finelt M, Pahwa S, Good RA, Naspitz CK, Mendes NF, et al. Cranial synostosis in Job’s syndrome. Lancet 1978; 1:826; http://dx.doi.org/10.1016/S0140-6736(78)93028-3; PMID: 85845
  • O’Connell AC, Puck JM, Grimbacher B, Facchetti F, Majorana A, Gallin JI, et al. Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89:177 - 85; http://dx.doi.org/10.1067/moe.2000.103129; PMID: 10673653
  • Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med 1999; 340:692 - 702; http://dx.doi.org/10.1056/NEJM199903043400904; PMID: 10053178
  • Freeman AF, Avila EM, Shaw PA, Davis J, Hsu AP, Welch P, et al. Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol 2011; 31:338 - 45; http://dx.doi.org/10.1007/s10875-011-9515-9; PMID: 21494893
  • Freeman AF, Collura-Burke CJ, Patronas NJ, Ilcus LS, Darnell D, Davis J, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics 2007; 119:e1121 - 5; http://dx.doi.org/10.1542/peds.2006-2649; PMID: 17438082
  • Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, et al. Non-Hodgkin’s lymphoma in Job’s syndrome: a case report and literature review. Leuk Lymphoma 2004; 45:2521 - 5; http://dx.doi.org/10.1080/10428190400004463; PMID: 15621772
  • Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608 - 19; http://dx.doi.org/10.1056/NEJMoa073687; PMID: 17881745
  • Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007; 448:1058 - 62; http://dx.doi.org/10.1038/nature06096; PMID: 17676033
  • Mogensen TH, Jakobsen MA, Larsen CS. Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome. Scand J Infect Dis In press 2012; http://dx.doi.org/10.3109/00365548.2012.715750; PMID: 22992060
  • Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009; 361:2046 - 55; http://dx.doi.org/10.1056/NEJMoa0905506; PMID: 19776401
  • Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol 2012; 13:612 - 20; http://dx.doi.org/10.1038/ni.2305; PMID: 22581261
  • Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006; 25:745 - 55; http://dx.doi.org/10.1016/j.immuni.2006.09.009; PMID: 17088085
  • Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997; 94:3801 - 4; http://dx.doi.org/10.1073/pnas.94.8.3801; PMID: 9108058
  • Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12:383 - 90; http://dx.doi.org/10.1038/ni.2025; PMID: 21502992
  • Wang WB, Levy DE, Lee CK. STAT3 negatively regulates type I IFN-mediated antiviral response. J Immunol 2011; 187:2578 - 85; http://dx.doi.org/10.4049/jimmunol.1004128; PMID: 21810606
  • Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773 - 6; http://dx.doi.org/10.1038/nature06764; PMID: 18337720
  • Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 2012; 12:616 - 22; http://dx.doi.org/10.1097/ACI.0b013e328358cc0b; PMID: 23026768
  • Laan M, Cui ZH, Hoshino H, Lötvall J, Sjöstrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162:2347 - 52; PMID: 9973514
  • Hill HR, Ochs HD, Quie PG, Clark RA, Pabst HF, Klebanoff SJ, et al. Defect in neutrophil granulocyte chemotaxis in Job’s syndrome of recurrent “cold” staphylococcal abscesses. Lancet 1974; 2:617 - 9; http://dx.doi.org/10.1016/S0140-6736(74)91942-4; PMID: 4137601
  • Buckley RH, Becker WG. Abnormalities in the regulation of human IgE synthesis. Immunol Rev 1978; 41:288 - 314; http://dx.doi.org/10.1111/j.1600-065X.1978.tb01469.x; PMID: 360511
  • Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151 - 60; http://dx.doi.org/10.1056/NEJMoa021481; PMID: 12374875
  • Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, et al. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 2011; 4:448 - 55; http://dx.doi.org/10.1038/mi.2011.5; PMID: 21346738
  • Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009; 206:1291 - 301; http://dx.doi.org/10.1084/jem.20082767; PMID: 19487419
  • Speckmann C, Enders A, Woellner C, Thiel D, Rensing-Ehl A, Schlesier M, et al. Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 2008; 129:448 - 54; http://dx.doi.org/10.1016/j.clim.2008.08.002; PMID: 18835223
  • Avery DT, Deenick EK, Ma CS, Suryani S, Simpson N, Chew GY, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010; 207:155 - 71; http://dx.doi.org/10.1084/jem.20091706; PMID: 20048285
  • Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011; 35:806 - 18; http://dx.doi.org/10.1016/j.immuni.2011.09.016; PMID: 22118528
  • Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002; 298:1630 - 4; http://dx.doi.org/10.1126/science.1077002; PMID: 12446913
  • Wesemann DR, Magee JM, Boboila C, Calado DP, Gallagher MP, Portuguese AJ, et al. Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination. J Exp Med 2011; 208:2733 - 46; http://dx.doi.org/10.1084/jem.20111155; PMID: 22143888
  • Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, et al. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 2011; 208:235 - 49; http://dx.doi.org/10.1084/jem.20100799; PMID: 21300911
  • Panopoulos AD, Zhang L, Snow JW, Jones DM, Smith AM, El Kasmi KC, et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 2006; 108:3682 - 90; http://dx.doi.org/10.1182/blood-2006-02-003012; PMID: 16888100
  • Nieminen P, Morgan NV, Fenwick AL, Parmanen S, Veistinen L, Mikkola ML, et al. Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet 2011; 89:67 - 81; http://dx.doi.org/10.1016/j.ajhg.2011.05.024; PMID: 21741611
  • Kida H, Mucenski ML, Thitoff AR, Le Cras TD, Park KS, Ikegami M, et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol 2008; 172:1542 - 54; http://dx.doi.org/10.2353/ajpath.2008.071052; PMID: 18467707
  • Sekhsaria V, Dodd LE, Hsu AP, Heimall JR, Freeman AF, Ding L, et al. Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol 2011; 128:1124 - 7; http://dx.doi.org/10.1016/j.jaci.2011.07.046; PMID: 21872914
  • Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355:788 - 98; http://dx.doi.org/10.1056/NEJMoa055695; PMID: 16928994
  • Kovacic JC, Gupta R, Lee AC, Ma M, Fang F, Tolbert CN, et al. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest 2010; 120:303 - 14; http://dx.doi.org/10.1172/JCI40364; PMID: 20038813
  • Zhang Z, Welte T, Troiano N, Maher SE, Fu XY, Bothwell AL. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice. Biochem Biophys Res Commun 2005; 328:800 - 7; http://dx.doi.org/10.1016/j.bbrc.2005.01.019; PMID: 15694417
  • Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006; 12:829 - 34; http://dx.doi.org/10.1038/nm1425; PMID: 16783372
  • Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008; 122:1054 - 62, quiz 1063-4; http://dx.doi.org/10.1016/j.jaci.2008.10.023; PMID: 19084106
  • Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy 2011; 9:10; http://dx.doi.org/10.1186/1476-7961-9-10; PMID: 21624140
  • Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377:65 - 8; http://dx.doi.org/10.1038/377065a0; PMID: 7659163
  • Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20:394 - 7; http://dx.doi.org/10.1038/3877; PMID: 9843216
  • Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000; 191:771 - 80; http://dx.doi.org/10.1084/jem.191.5.771; PMID: 10704459
  • Buckley RH. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. J Allergy Clin Immunol 2010; 125:790 - 7; http://dx.doi.org/10.1016/j.jaci.2010.02.012; PMID: 20371393
  • Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349:1139 - 47; http://dx.doi.org/10.1056/NEJMoa022926; PMID: 13679528
  • Nadeau K, Hwa V, Rosenfeld RG. STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr 2011; 158:701 - 8; http://dx.doi.org/10.1016/j.jpeds.2010.12.042; PMID: 21414633
  • Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001; 293:300 - 3; http://dx.doi.org/10.1126/science.1061154; PMID: 11452125
  • Haverkamp MH, van Dissel JT, Holland SM. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Microbes Infect 2006; 8:1157 - 66; http://dx.doi.org/10.1016/j.micinf.2005.10.029; PMID: 16520075
  • Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280:1432 - 5; http://dx.doi.org/10.1126/science.280.5368.1432; PMID: 9603732
  • Sancho-Shimizu V, Zhang SY, Abel L, Tardieu M, Rozenberg F, Jouanguy E, et al. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr Opin Allergy Clin Immunol 2007; 7:495 - 505; http://dx.doi.org/10.1097/ACI.0b013e3282f151d2; PMID: 17989525
  • Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev 2008; 226:29 - 40; http://dx.doi.org/10.1111/j.1600-065X.2008.00698.x; PMID: 19161414
  • Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011; 208:1635 - 48; http://dx.doi.org/10.1084/jem.20110958; PMID: 21727188